That would be the research agenda for June. What would be required for listing on schedule 1 would be a full risk assessment. The very clear message from the best brains exchange and the science symposium is that there are significant gaps in research. We are looking at making sure we have the most robust science assessment and that we take the appropriate regulatory steps.
On May 13th, 2019. See this statement in context.